Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00117377 · ClinicalTrials.gov registry record · Phase 4

Effects of Pimecrolimus Cream 1% on the Molecular and Cellular Profile of Adult Male Patients With Atopic Dermatitis

A Phase 4 study of Atopic Dermatitis, sponsored by Novartis.

Completed
Registry status
Phase 4
Development phase
70
Enrollment target
3
Study locations

NCT00117377 is a Phase 4 study of Atopic Dermatitis that has completed, run by Novartis. The registered enrollment target is 70 participants, below the 609-participant average among 150 other Atopic Dermatitis trials with a reported enrollment target (89% lower). The trial reports 3 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00117377, a Phase 4 study of Atopic Dermatitis, has completed, sponsored by Novartis.

COMPLETED
Registry status
Phase 4
Development phase
70 participants
Enrollment target
3
Study locations

Study Summary

The purpose of this study is to identify how pimecrolimus cream 1% modifies the molecular and cellular changes associated with the post-lesional phase of atopic dermatitis (AD). Healthy volunteers and patients with atopic dermatitis will be studied.

Conditions Studied

Atopic Dermatitis

Interventions

  • DRUG Placebo
  • DRUG Pimecrolimus

Study Locations (3)

New York

  • Mount Sinai School of Medicine - New York
  • New York University Hospital - New York

Virginia

  • Virginia Clinical Research, Inc - Norfolk

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2004-04
Est. Completion 2005-06
Phase Phase 4

Sponsor

Novartis

265 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00117377

The ClinicalTrials.gov registry entry for NCT00117377 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 609-participant average among 150 other Atopic Dermatitis trials with a reported enrollment target (89% lower). The listed sponsor is Novartis, which has 265 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Atopic Dermatitis appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT00117377 reports 3 study locations spanning 2 distinct geographic areas - top geographies include New York, Virginia.

Frequently Asked Questions

What is clinical trial NCT00117377 about?

NCT00117377 is a clinical study titled "Effects of Pimecrolimus Cream 1% on the Molecular and Cellular Profile of Adult Male Patients With Atopic Dermatitis". The purpose of this study is to identify how pimecrolimus cream 1% modifies the molecular and cellular changes associated with the post-lesional phase of atopic dermatitis (AD). Healthy volunteers and patients with atopic dermatitis will be studied.

What is the current status of trial NCT00117377?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 70 participants. The study started on 2004-04. Estimated completion is 2005-06.

What conditions does trial NCT00117377 study?

This clinical trial studies the following conditions: Atopic Dermatitis.

What interventions are being tested in trial NCT00117377?

The interventions under investigation include: Placebo (DRUG), Pimecrolimus (DRUG).

Who is sponsoring clinical trial NCT00117377?

This trial is sponsored by Novartis, which has 265 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00117377 being conducted?

This trial has 3 study locations across New York, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Atopic Dermatitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Atopic Dermatitis

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.